Publication Name	World Journal of Neurology
Manuscript ID	14330
Country	Egypt

Received	2014-09-29 10:00
Peer-Review Started	2014-09-29 21:17
To Make the First Decision	2014-11-27 12:17
Return for Revision	2014-12-03 08:33
Revised	2015-01-10 00:00
Second Decision	2015-01-28 11:39
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-02-09 09:57
Articles in Press	2015-02-09 09:57
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-03-26 19:12
Publish the Manuscript Online	2015-03-31 10:53

ISSN	2218-6212 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Pharmacology & Pharmacy
Manuscript Type	Review
Article Title	Prevalence, clinical features and treatment of depression in Parkinson’s disease: An update
Manuscript Source	Invited Manuscript
All Author List	Omar ME Abdel-Salam
Funding Agency and Grant Number
Corresponding Author	Omar ME Abdel-Salam, MD, PhD, Department of Toxicology and Narcotics, Medical Division, National Research Centre, Tahrir St., Dokki, Cairo 12311, Egypt. omasalam@hotmail.com
Key Words	Antidepressant drugs; Depression; Serotonin reuptake inhibitors; Parkinson’s disease; Tricyclic antidepressants
Core Tip	The development of depressive symptoms in Parkinson’s disease (PD) has important implications on the daily functioning and quality of life. It is thus important to diagnose and treat depression effectively in these patients. This review aims to discuss the prevalence, associated factors and drugs used to treat depressive symptoms in PD.
Publish Date	2015-03-31 10:53
Citation	Abdel-Salam OME. Prevalence, clinical features and treatment of depression in Parkinson’s disease: An update. World J Neurol 2015; 5(1): 17-38
URL	http://www.wjgnet.com/2218-6212/full/v5/i1/17.htm
DOI	http://dx.doi.org/10.5316/wjn.v5.i1.17

Full Article (PDF)	WJN-5-17.pdf
Full Article (Word)	WJN-5-17.doc
Manuscript File	14330-Review.doc
Answering Reviewers	14330-Answering reviewers.pdf
Conflict-of-Interest Disclosure Form	14330-Conflict-of-interest statement.pdf
Copyright License Agreement	14330-Copyright assignment.pdf
Peer-review Report	14330-Peer-review(s).pdf
Scientific Misconduct Check	14330-Scientific misconduct check.pdf
Scientific Editor Work List	14330-Scientific editor work list.pdf